Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-102.58M
↓ 29% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthFair Value
Average
$-79.80M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-102.58M | +22.4% |
| 2024 | $-132.19M | +12.5% |
| 2023 | $-151.02M | -1.3% |
| 2022 | $-149.16M | +1.9% |
| 2021 | $-152.11M | -420.0% |
| 2020 | $-29.25M | -31.8% |
| 2019 | $-22.19M | +3.2% |
| 2018 | $-22.93M | +16.4% |
| 2017 | $-27.44M | -198.7% |
| 2016 | $-9.19M | - |